New patent for the drug Galderma Labs AKLIEF – DrugPatentWatch
Annual Drug Patent Expiration for AKLIEF
Aklief is a drug marketed by Galderma Labs Lp and included in one NDA. It is available from a single supplier. There are five patents protecting this drug.
AKLIEF drug price trends.
This drug has fifty-six patent family members in twenty-eight countries.
The generic ingredient in AKLIEF is trifarotene. One registered supplier for this compound. Additional details are available on the triparotene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for the drug Galderma Labs AKLIEF
